21 min listen
Coronavirus Vaccine FDA Update
ratings:
Length:
26 minutes
Released:
Dec 16, 2020
Format:
Podcast episode
Description
Peter W. Marks, MD, PhD, and Stephen M. Hahn, MD, return to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the data, the weekend's EUA designation (Pfizer/BioNTech), and the process for future full licensure and postmarketing safety surveillance. Dr Marks directs the US FDA's Center for Biologics Evaluation and Research (CBER). Dr Hahn is commissioner of the US Food and Drug Administration. Recorded December 14, 2020. Related Article(s): Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program
Released:
Dec 16, 2020
Format:
Podcast episode
Titles in the series (100)
The Effect of the COVID-19 Pandemic on Clinic Operations: Seattle has been a focal point for the US in the coronavirus pandemic. Doug Paauw, MD, professor of medicine at the University of Washington, in Seattle, describes the UW primary care clinic experience as this pandemic evolved. Major lessons learned... by Coronavirus (COVID-19) Q&A